Iron supplements can cause joint pain, though the risk depends heavily on whether you are taking oral tablets or receiving iron intravenously. Intravenous iron formulations are the more established culprits, with one study finding that roughly 40% of patients given a total-dose infusion of iron dextran developed joint and muscle pain afterward. Oral iron supplements carry a subtler and less direct connection to joint symptoms, but emerging evidence on iron’s effects on cartilage, bone metabolism, and gut health suggests the relationship is real for some people. The story is more complex than a simple yes or no, and it matters which form of iron you take, how much, and whether you already have joint problems.
Intravenous Iron and the Arthralgia-Myalgia Syndrome
The clearest link between iron supplements and joint pain involves intravenous formulations. When iron dextran is given as a total-dose infusion, a well-documented side effect called the arthralgia-myalgia syndrome can follow. In a double-blind randomized trial studying this problem, the syndrome developed in about 40% of treated patients.1Journal of Laboratory and Clinical Medicine. Value of methylprednisolone in prevention of the arthralgia-myalgia syndrome associated with the total dose infusion of iron dextran: A double blind randomized trial Symptoms include aching joints and muscles that begin within a day or two of the infusion. That is not a rare side effect by any stretch.
Other intravenous iron products can trigger similar reactions. In one documented case, a woman receiving ferric gluconate developed transient pain in her knee and wrist joints after the first infusion of 125 mg. After a second infusion, she experienced severe leg pain, muscular and joint stiffness, and functional impairment of her hands, foot, and ankle.2PubMed Central. Rhabdomyolysis after Intravenous Ferric Gluconate: A Case Report In that case, the researchers concluded that intravenous iron likely generated excess free iron that promoted oxidative injury in joints and muscles. The progression from mild, transient discomfort after the first dose to severe symptoms after the second is a pattern worth noting: it suggests a cumulative effect rather than a one-off reaction.
How Excess Iron Damages Cartilage
The biological mechanism connecting iron and joint damage is not mysterious. When iron accumulates beyond what the body can safely store, it generates reactive oxygen species through a chemical pathway called the Fenton reaction. These free radicals attack cartilage cells directly. Laboratory research has shown that iron overload reduces production of collagen II (the primary structural protein in cartilage), disrupts the normal cell cycle in chondrocytes, and increases cell death compared to untreated controls.3PubMed Central. Iron Overload Induces Oxidative Stress, Cell Cycle Arrest and Apoptosis in Chondrocytes In plain terms, too much iron poisons the very cells responsible for maintaining healthy joint cartilage.
A review examining how iron overload connects to osteoarthritis elaborated on this process. When intracellular iron is excessive, hydroxyl free radicals promote lipid peroxidation, which damages cell membranes and can trigger a specific type of cell death called ferroptosis.4Frontiers in Cell and Developmental Biology. Interplay Between Iron Overload and Osteoarthritis: Clinical Significance and Cellular Mechanisms This is not just a theoretical concern from test tubes. The connection between iron and joint tissue damage has been observed directly in human tissue samples. An ultrastructural study of synovial tissue (the lining inside joints) found iron deposits in the synovial cells of patients with rheumatoid arthritis, hemophilic synovitis, and other inflammatory joint conditions, with considerable tissue damage noted near iron-rich deposits.5Annals of the Rheumatic Diseases. Relationship between iron deposits and tissue damage in the synovium: an ultrastructural study
More recent imaging work confirms this in living patients. MRI-based measurements of synovial iron found significantly higher iron levels in the joint lining of rheumatoid arthritis patients compared to those with osteoarthritis, and those iron levels correlated with bone erosion.6PubMed Central. MRI-Based Synovial Iron Quantification Associates with Bone Erosion in Rheumatoid Arthritis The take-home message from this body of research is that iron does not need to circulate at astronomically high levels to cause joint problems. Localized iron deposits inside a joint can do real damage to the tissue they contact.
The Phosphate Problem With Certain IV Iron Products
There is a second, entirely separate mechanism by which intravenous iron causes bone and joint pain, and it involves phosphate rather than direct iron toxicity. Certain IV iron formulations, particularly ferric carboxymaltose (often sold as Injectafer or Ferinject), can trigger a dramatic drop in blood phosphate levels. When phosphate stays low for weeks to months in people who need repeated infusions, the result can be a painful bone-softening condition called osteomalacia.
The mechanism works through a hormone called FGF23. Clinical trials have established that ferric carboxymaltose causes FGF23 levels to spike within 24 hours, which in turn drives the kidneys to flush phosphate out through urine. This leads to drops in serum phosphate, calcium, and active vitamin D levels.7PubMed Central. Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome A case report described a patient who developed severe osteomalacia with bone pain from repeated ferric carboxymaltose infusions, directly attributable to this FGF23-driven phosphate wasting.8BMJ Case Reports CP. Severe FGF23-based hypophosphataemic osteomalacia due to ferric carboxymaltose administration The bone pain from this condition can easily be mistaken for joint pain, and the two often coexist.
Not all IV iron products carry the same risk. Iron dextran does not appear to trigger the same FGF23 spike that ferric carboxymaltose does. If you are getting IV iron and notice new musculoskeletal pain, ask your doctor to check your phosphate level. A simple blood test can reveal whether this mechanism is at play, and the fix (phosphate supplementation or switching to a different iron formulation) is straightforward once the cause is identified.
Iron and Pseudogout
Iron overload can also trigger joint pain through crystal deposition. In conditions like hereditary hemochromatosis, excess iron damages cartilage and increases the concentration of inorganic pyrophosphate in the joint space. This promotes the formation of calcium pyrophosphate crystals, which deposit in cartilage and can cause sudden, intensely painful joint attacks known as pseudogout.9Medical Laboratory Journal. Diagnostic value of polarized optical microscopy in pseudogout: A review of calcium pyrophosphate deposition disease in the clinical laboratory The pattern typically affects the knees, wrists, and other large joints, and the attacks can mimic gout closely enough to confuse diagnosis.
Hemochromatosis is usually a genetic condition, but secondary iron overload from prolonged, heavy supplementation or repeated transfusions can produce the same joint problems. This form of hemochromatosis-related arthritis occurs when systemic iron overload deposits in joints due to massive or repeated iron exposure over time. The implication for people on long-term iron supplementation is clear: chronic oversupplementation carries a real, if uncommon, risk of crystal-deposition joint disease that persists even after iron levels are corrected.
When Iron Supplements Worsen Existing Joint Disease
If you already have an inflammatory joint condition like rheumatoid arthritis, iron supplements deserve extra caution. A study of eleven rheumatoid arthritis patients who received total-dose IV iron dextran for anemia found that nine out of eleven experienced a flare of their synovitis. Using thermal imaging to measure joint inflammation, researchers found that inflammation increased in two or more joint areas in every patient examined. Small joints of the hands were most affected, though larger joints that were already inflamed also worsened. Uninflamed joints were rarely affected. The flare typically began 24 to 48 hours after the infusion and coincided with saturation of the blood’s iron-binding capacity.10PubMed. Effect of intravenous iron dextran on rheumatoid synovitis The researchers concluded that free iron beyond what transferrin could bind was driving lipid peroxidation in the joint lining.
This does not mean people with rheumatoid arthritis should never receive IV iron. Anemia is extremely common in RA, and leaving it untreated carries its own problems. A literature review found significant evidence that newer, less immunogenic IV iron preparations like iron sucrose and low-molecular-weight iron dextran can be used safely in RA patients.11PubMed. The safety of modern intravenous iron infusions in patients with rheumatoid arthritis – a review of the literature The older high-molecular-weight iron dextran formulations that caused the dramatic flares in the study above have largely been replaced by products that release iron more gradually and are less likely to overwhelm the body’s binding capacity. The practical lesson is that the choice of formulation matters, and your rheumatologist should be involved in deciding which iron product to use.
Oral Iron, Dietary Iron, and Osteoarthritis Progression
Most people searching this question are probably taking oral iron tablets, not getting infusions. The connection between standard oral supplements and joint pain is less dramatic but still worth understanding. Oral iron supplements do not typically flood the bloodstream the way IV products do, because intestinal absorption is tightly regulated. Your gut will only absorb a fraction of each dose, and that fraction decreases as your iron stores rise. This built-in safety valve makes acute joint reactions from oral iron uncommon.
However, chronic excessive iron intake does appear to affect joints over time. A study that tracked knee osteoarthritis progression found a U-shaped relationship between iron intake and the risk of disease worsening. Below about 16.5 mg per day of total iron intake, each additional milligram was associated with a lower risk of osteoarthritis progression. Above that threshold, additional iron was associated with a higher risk: for each additional milligram per day above 16.5 mg, the risk of radiographic worsening increased by roughly 20%.12PubMed Central. Association between Iron Intake and Progression of Knee Osteoarthritis A similar pattern held for joint-space narrowing, with a threshold around 16 mg per day.
To put that in context, a typical iron supplement tablet contains 65 mg of elemental iron, and many people also get 10 to 18 mg from food. If you are taking a standard supplement on top of an iron-adequate diet, your total intake could easily exceed the threshold where more iron starts to hurt rather than help your joints. This does not mean a single supplement tablet will destroy your knees. It means that months or years of unnecessary supplementation, particularly if you are not actually iron deficient, could contribute to joint deterioration. The people most at risk are those self-supplementing without lab confirmation of deficiency.
Iron, the Gut Microbiome, and Systemic Inflammation
An indirect path from iron supplements to joint symptoms runs through the gut. Elevated iron levels in the intestine alter the composition of the gut microbiome, favoring pathogenic bacteria while suppressing protective species like bifidobacteria and lactobacilli.13PubMed. Current iron therapy in the light of regulation, intestinal microbiome, and toxicity: are we prescribing too much iron? The resulting dysbiosis can contribute to gastrointestinal inflammation, and growing evidence links gut inflammation to systemic inflammatory responses, including in the joints.
This connection is still being studied, and it would be premature to say that your iron supplement is giving you sore knees by disrupting your gut bacteria. But it adds another layer to why taking iron you do not need is not harmless. The gut microbiome effects are dose-dependent, and they compound over time. If you are experiencing both digestive symptoms and joint discomfort while on iron supplements, the two may share a common driver.
Reducing the Risk of Joint Symptoms From Iron
The most important step is straightforward: do not take iron supplements unless you have confirmed iron deficiency. A serum ferritin test and a complete blood count can determine whether you actually need supplementation. Many people start iron based on fatigue alone, which has dozens of possible causes unrelated to iron status. Supplementing when your stores are already adequate does nothing for your energy and starts pushing you toward the excess-iron end of the spectrum where joint risks increase.
If you do need oral iron, dosing strategy matters. Research has found that alternate-day dosing may be preferable to daily dosing. Iron absorption from a single dose given every other day was roughly double the absorption from the same dose given daily, because the body’s absorption-regulation mechanism (driven by hepcidin) resets between doses.14Haematologica. Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women A retrospective cohort study concluded that a single daily dose or a slightly greater alternate-day dose is generally the ideal approach for minimizing side effects while maximizing absorption.15PubMed Central. Comparing therapeutic effects of alternate day versus daily oral iron in women with iron deficiency anemia: A retrospective cohort study Lower unabsorbed iron in the gut also means less disruption to your microbiome.
For those receiving IV iron, ask about the specific formulation and whether your provider has considered the risk of hypophosphatemia, especially if you will need repeat infusions. If you have an existing inflammatory joint condition, newer iron preparations have a better safety profile than older high-molecular-weight iron dextran products. And if you develop new or worsening joint symptoms within a few days of an infusion, report it. Clinicians sometimes attribute post-infusion aches to a vague “infusion reaction” without investigating whether iron-specific mechanisms like phosphate wasting or synovial iron loading are involved.
Who Should Be Most Careful
Certain groups face higher risk from iron-related joint effects. People with hereditary hemochromatosis absorb far more dietary iron than average, so even moderate supplementation can push them into overload territory rapidly. Anyone receiving regular blood transfusions for chronic conditions like thalassemia or myelodysplastic syndromes accumulates iron with each unit of blood, and supplementation on top of that is dangerous. People with existing osteoarthritis should be aware that excessive iron intake may accelerate cartilage loss, based on the U-shaped relationship between iron intake and disease progression described earlier. And people with rheumatoid arthritis or other inflammatory joint diseases face the dual risk of iron-driven oxidative damage to an already inflamed joint lining and potential disease flares after IV iron, though modern formulations have reduced that risk considerably.
People with chronic kidney disease represent another group that deserves mention. They often receive IV iron regularly as part of anemia management, and they may also have abnormal phosphate regulation to begin with. Adding FGF23-mediated phosphate wasting from ferric carboxymaltose on top of existing mineral imbalances can accelerate bone disease. If you fall into any of these categories and are experiencing joint symptoms, bring up iron specifically with your doctor rather than assuming the two are unrelated.